106 related articles for article (PubMed ID: 15215827)
1. Biologists take degrading route to tackle cancer.
Abbott A
Nature; 2004 Jun; 429(6994):794. PubMed ID: 15215827
[No Abstract] [Full Text] [Related]
2. [Proteases in malignant tumors. Their significance for pathogenesis and possible therapeutic consequences].
Fröhlich E
Dtsch Med Wochenschr; 2004 Feb; 129(8):391-5. PubMed ID: 14961448
[No Abstract] [Full Text] [Related]
3. [Antiproteases in the pathogenesis of neoplastic diseases].
Dabrowska M
Przegl Lek; 1998; 55(9):475-9. PubMed ID: 10085727
[TBL] [Abstract][Full Text] [Related]
4. Broken promises.
Nature; 2008 Apr; 452(7187):503. PubMed ID: 18385689
[No Abstract] [Full Text] [Related]
5. [The role of proteolytic enzymes and their inhibitors in malignant neoplasm invasion (literature review)].
Oglovlina OG; Aref'eva TI
Biokhimiia; 1994 Mar; 59(3):340-52. PubMed ID: 8180267
[TBL] [Abstract][Full Text] [Related]
6. NIH common fund concerns some in cancer research community.
Vanchieri C
J Natl Cancer Inst; 2007 Mar; 99(5):345. PubMed ID: 17341723
[No Abstract] [Full Text] [Related]
7. Proteases and protease inhibitors in cancer.
Van Noorden CJ
Acta Histochem; 1998 Nov; 100(4):344-54. PubMed ID: 9842415
[TBL] [Abstract][Full Text] [Related]
8. Gene therapy rising?
Hoag H
Nature; 2005 May; 435(7041):530-1. PubMed ID: 15917820
[No Abstract] [Full Text] [Related]
9. Researchers facing increasing costs for clinical research, with few solutions.
Erdmann J
J Natl Cancer Inst; 2005 Oct; 97(20):1492-4. PubMed ID: 16234558
[No Abstract] [Full Text] [Related]
10. Extracellular proteases as targets for treatment of cancer metastases.
Lee M; Fridman R; Mobashery S
Chem Soc Rev; 2004 Sep; 33(7):401-9. PubMed ID: 15354221
[TBL] [Abstract][Full Text] [Related]
11. Europe finds US$ 200 million to support African clinical trials.
Walgate R
Bull World Health Organ; 2002; 80(10):843. PubMed ID: 12471411
[No Abstract] [Full Text] [Related]
12. [Proteases and protease inhibitors in the treatment of cancer].
Brünner NA
Ugeskr Laeger; 1999 Mar; 161(11):1577-80. PubMed ID: 10202439
[No Abstract] [Full Text] [Related]
13. [Can independent clinical research survive?].
Aapro MS; Leyvraz S
Rev Med Suisse; 2005 May; 1(20):1323-4. PubMed ID: 15991623
[No Abstract] [Full Text] [Related]
14. National Heart, Lung, and Blood Institute resources and programs for gene therapy in heart, lung, and blood diseases.
Skarlatos SI
Circ Res; 2007 Jun; 100(12):1667-9. PubMed ID: 17585073
[No Abstract] [Full Text] [Related]
15. No more boring science, no more waste in clinical trials.
Laurence J
Transl Res; 2009 Jan; 153(1):1-3. PubMed ID: 19100951
[No Abstract] [Full Text] [Related]
16. The Canadian Clinical Research Initiative: transforming Canadian clinical research capacity.
Cairns JA
Clin Invest Med; 2004 Dec; 27(6):292-5. PubMed ID: 15675108
[No Abstract] [Full Text] [Related]
17. The commercialization of clinical research: who pays the piper, calls the tune?
Freemantle N; Stocken D
Fam Pract; 2004 Aug; 21(4):335-6. PubMed ID: 15249519
[No Abstract] [Full Text] [Related]
18. Clinical Cancer Advances 2009: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology.
Petrelli NJ; Winer EP; Brahmer J; Dubey S; Smith S; Thomas C; Vahdat LT; Obel J; Vogelzang N; Markman M; Sweetenham JW; Pfister D; Kris MG; Schuchter LM; Sawaya R; Raghavan D; Ganz PA; Kramer B
J Clin Oncol; 2009 Dec; 27(35):6052-69. PubMed ID: 19901123
[No Abstract] [Full Text] [Related]
19. Independent medical research.
van der Meer JW; de Gier AM; van Swaaij WP; Katan MB
Neth J Med; 2007 Apr; 65(4):124-6. PubMed ID: 17452759
[No Abstract] [Full Text] [Related]
20. Four important steps toward 21st century care for patients with cancer.
McClellan M; Benner JS
Oncologist; 2009 Apr; 14(4):313-6. PubMed ID: 19365095
[No Abstract] [Full Text] [Related]
[Next] [New Search]
